News
Market Data
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current IPH market cap is 170.62M. The company's latest EPS is EUR -0.7186 and P/E is -2.94.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 93.95M | 85.81M | 71.32M | 26.5M | 57.89M |
| Operating Income | 5.21M | -27.05M | -62.08M | -54.98M | -57.53M |
| Net Income | 3.05M | -20.76M | -63.98M | -52.81M | -58.1M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 451.22M | 401.36M | 307.42M | 267.5M | 207.86M |
| Total Liabilities | 283.98M | 183.95M | 151.45M | 160.06M | 153.71M |
| Total Equity | 167.24M | 217.42M | 155.98M | 107.44M | 54.15M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -32.53M | 34.92M | -51.77M | -58.46M | -19.15M |
| Investing | 24.28M | -62.12M | -13.37M | -917k | 1.88M |
| Financing | 61.22M | 77.77M | -1.18M | 26.82M | -1.83M |
| Market Cap | 170.62M |
| Price to Earnings Ratio | -2.94 |
| Price to Sales Ratio | 2.95 |
| Price to Cash Ratio | 2.03 |
| Price to Book Ratio | 3.15 |
| Dividend Yield | - |
| Shares Outstanding | 80.86M |
| Average Volume (1 week) | 81.15k |
| Average Volume (1 Month) | 63.97k |
| 52 Week Change | -30.25% |
| 52 Week High | 3.345 |
| 52 Week Low | 2.11 |
| Spread (Intraday) | 0.06 (2.76%) |
| Company Name | Innate Pharma |
| Address |
117 avenue de luminy marseille, bouches-du-rhone 13009 |
| Website | https://www.innate-pharma.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
